[1]
Muhammad Ayaz et al. 2024. NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY IN PATIENTS OF ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION CANCER (SINGLE INSTITUTE STUDY). Journal of Population Therapeutics and Clinical Pharmacology. 31, 7 (Jul. 2024), 1715–1723. DOI:https://doi.org/10.53555/k561hf62.